miR-21 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

miR-21 overexpression	Breast Cancer	miR-21 overexpression	Breast Cancer	bevacizumab Sensitive: B - Late Trials bevacizumab Sensitive : B	bevacizumab Sensitive: B - Late Trials bevacizumab Sensitive : B
miR-21 overexpression	HER2 Positive Breast Cancer	miR-21 overexpression	HER2 Positive Breast Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3

Associations